Neurocrine Biosciences, Inc <NBIX.O>: BMO Raises Target Price to $170 From $144
NBIX•Related News
Halliburton wins integrated drilling, completions contract for TotalEnergies’ GranMorgu project offshore Suriname
HAL•
Banzai plans to use USD 0.9 million stock offering proceeds for working capital, general corporate purposes
BNZI•
Xeriant says press release available on NEXBOARD third-party test results
XERI•
US bank First Hawaiian bets on mainland growth with $2 billion TriCo buy
FHB•
Charles River to provide GMP NGS testing services to Arovella Therapeutics under new collaboration
CRL•